Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · ProShares

PHPIX Holdings: What Pharmaceuticals Ultrasector Profund Owns

Ticker PHPIX · Since 2000-06-28 · · Holdings as of Jul 31, 2026

Expense ratio
1.78%$178/yr per $10k
5-yr return
+1.6%annualized
1-yr return
+1.4%as of Dec 2024
Net assets
$8.6Mall share classes
Holdings
74

Bottom line

What does PHPIX hold?

PHPIX held 74 positions as of Jul 31, 2026. Its largest holding is N/a at 8.20% of the fund, and the top 10 positions add up to 39.1%. By asset type it is 71% stocks, 30% repurchase agreements.

Updated Sep 23, 2026

PHPIX top 25 holdings

#HoldingType% of fundValue
1 N/a
SOCIETE' GENERALE 3.53 , 8/03/2026
Repurchase agreements 8.20%$703.0K
2 N/a
CF Secured 3.53 , 8/03/2026
Repurchase agreements 6.31%$541.0K
3 N/a
HSBC SECURITIES (USA), INC. 3.52 , 8/03/2026
Repurchase agreements 5.05%$433.0K
4 N/a
NATWEST MARKETS PLC 3.51 , 8/03/2026
Repurchase agreements 5.05%$433.0K
5 N/a
UMB FINANCIAL CORP. 3.39 , 8/03/2026
Repurchase agreements 3.95%$339.0K
6 Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc.
Stocks 2.60%$223.4K
7 Mbx Biosciences Inc
MBX Biosciences, Inc.
Stocks 2.28%$195.4K
8 Ataibeckley Inc
AtaiBeckley, Inc.
Stocks 2.03%$174.4K
9 Definium Therapeutics Inc
Definium Therapeutics, Inc.
Stocks 2.00%$171.9K
10 Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals, Inc.
Stocks 1.62%$138.5K
11 Enliven Therapeutics Inc
Enliven Therapeutics, Inc.
Stocks 1.59%$136.0K
12 Corcept Therapeutics Inc
Corcept Therapeutics, Inc.
Stocks 1.57%$134.5K
13 Alumis Inc
Alumis, Inc.
Stocks 1.51%$129.3K
14 N/a
ROYAL BANK OF CANADA 3.44 , 8/03/2026
Repurchase agreements 1.49%$128.0K
15 Nuvation Bio Inc
Nuvation Bio, Inc.
Stocks 1.48%$126.9K
16 Trevi Therapeutics Inc
Trevi Therapeutics, Inc.
Stocks 1.46%$125.0K
17 Liquidia Corp
Liquidia Corporation
Stocks 1.38%$118.3K
18 Nektar Therapeutics
Nektar Therapeutics
Stocks 1.33%$114.3K
19 Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc.
Stocks 1.28%$109.8K
20 Bristol-myers Squibb Company
Bristol-Myers Squibb Company
Stocks 1.26%$107.8K
21 Edgewise Therapeutics Inc
Edgewise Therapeutics, Inc.
Stocks 1.25%$107.2K
22 Omeros Corp
Omeros Corporation
Stocks 1.24%$106.6K
23 Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals, Inc.
Stocks 1.24%$106.4K
24 Elanco Animal Health Inc
Elanco Animal Health, Inc.
Stocks 1.23%$105.8K
25 Veradermics Inc
VeraDermics, Inc.
Stocks 1.21%$103.6K

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026

Asset mix

Stocks70.6%
Repurchase agreements30.1%

Country exposure

CA2.0%
GB1.2%
IE2.2%
KY0.7%
SG1.0%
US92.9%